Financials

  • Market Capitalization 286.03 M
  • Employee 293
  • Founded 2000
  • CEO N/A
  • Website www.macrogenics.com
  • Headquarter Delaware, United States
  • FIGI BBG000BM2SF8
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.36
Price to sales ratio
0.68

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3355
INDP
Indaptus Therapeutics, Inc. - Common Stock
2.63 USD0.00%-1.13%-27.35%+38.42%297.83 M USD
3360
NMRA
Neumora Therapeutics, Inc. - Common Stock
1.60 USD-4.76%-4.19%+72.04%+24.03%296.45 M USD
3390
SABS
SAB Biotherapeutics, Inc. - Common Stock
3.73 USD-2.36%-4.60%+8.43%+54.13%285.21 M USD
3394
TTRX
Turn Therapeutics Inc. - Common Stock
9.47 USD+0.32%+19.27%+53.24%-5.30%282.09 M USD

Frequently asked questions about MacroGenics, Inc. - Common Stock

What is the MacroGenics, Inc. - Common Stock stock price today?

The current price of MacroGenics, Inc. - Common Stock (MGNX) is 4.5. Over the past 24 hours, the stock has changed by +3.93%. Follow the MGNX chart for real-time price dynamics.

What is the stock ticker of MacroGenics, Inc. - Common Stock?

MacroGenics, Inc. - Common Stock trades under the ticker MGNX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is MacroGenics, Inc. - Common Stock stock going up?

MGNX has changed by -2.17% over the last week, +13.64% over the last month, and +186.62% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was MacroGenics, Inc. - Common Stock net income for the last quarter?

MacroGenics, Inc. - Common Stock reported net income of -36.77 M for the last quarter. The previous quarter showed -14.15 M, which means net income changed by -159.80%.

How many employees does MacroGenics, Inc. - Common Stock have?

As of the latest available data, MacroGenics, Inc. - Common Stock has 293 employees. Workforce size can provide additional context about the company's scale and operations.

What is MacroGenics, Inc. - Common Stock EBITDA?

MacroGenics, Inc. - Common Stock EBITDA is -31.75 M, and its EBITDA margin is -152.84%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy MacroGenics, Inc. - Common Stock stock?

You can buy MacroGenics, Inc. - Common Stock (MGNX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in MacroGenics, Inc. - Common Stock stock?

Investing in MacroGenics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MGNX chart and related analysis on metatrader.com as part of your research.

News